December 09, 2022
Data from an analysis of patients in Denmark provides an overview of the effects of statin therapy on risk of intracerebral hemorrhage, with insights into how this benefit may vary based on the location of the intracerebral hemorrhage.
October 27, 2022
An analysis of data from a quality improvement initiative demonstrates the majority of patients continue their anticoagulant regimen beyond the guideline-directed 3 months following provoked VTE.
September 23, 2022
A new study encompassing data from more than 48,000,000 patients provides insight into the risk of major arterial and cerebrovascular diseases up to 49 weeks following initial COVID-19 diagnosis.
July 21, 2022
An analysis of data from the ARIC study provides insight into the impact of genetic risk scores on lifetime risk of stroke and how optimal cardiovascular health might influence this risk.
July 18, 2022
An analysis of data from more than 30k patients with DVT from the RIETE registry is providing clinicians with new insight into the difference in presentation and outcomes among patients with isolated distal DVT and proximal DVT.
June 28, 2022
An analysis of data from a single center in Switzerland from a 15-year period details the prevalence of undiagnosed major risk factors among patients admitted with acute ischemic stroke, suggesting 67.7% present with at least 1 undiagnosed risk factor.
June 27, 2022
Dr. Gregory Weiss provides perspective on a recent study detailing the risks of thrombosis observed with different COVID-19 vaccines among patients from a group of countries in Europe.
May 28, 2022
Our cardiology month in review spotlights the most popular content from the past month. This month's top articles include news from DELIVER, new guidelines for ICH and PFO, and a juxtaposition of international heart failure guidelines.
May 25, 2022
A post hoc analysis of the AUGUSTUS trial provides an overview of the effects of various antithrombotic regimens after ACS or PCI in patients with AFib and a history of stroke, TIA, or thromboembolism.
May 24, 2022
An analysis of national data from Sweden suggests men with prostate cancer were at a 48% greater risk of deep vein thrombosis and a 47% greater risk of pulmonary embolism compared to their counterparts without prostate cancer.